• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.48% Nasdaq Up 0.29%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    5.27 Down 0.04(0.75%) 4:00PM EDT
    |After Hours : 5.27 0.00 (0.00%) 4:36PM EDT
    Prev Close:5.31
    Open:5.36
    Bid:4.80 x 1500
    Ask:5.36 x 1000
    1y Target Est:6.30
    Beta:0.287232
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:5.19 - 5.39
    52wk Range:2.85 - 13.58
    Volume:279,009
    Avg Vol (3m):534,125
    Market Cap:157.37M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):517.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.33
    Quarterly EPS Est (Jun-16) :-0.34
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback